Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Biologics Completes FDA Inspection | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cytovance Biologics Completes FDA Inspection

The successful five-day process focused on quality systems, facilities, maintenance programs and manufacturing

By: Betsy Louda

, Contract Pharma

Cytovance Biologics has announced that the United States Food & Drug Administration (FDA) has concluded a successful Pre-License Inspection at Cytovance with no 483 observations. 


The focus of the five-day PLI was quality systems, facilities, maintenance programs and the manufacturing of client’s candidate product.

“We are very pleased with the result of the FDA inspection demonstrating Cytovance’s unwavering commitment to quality and patient safety,” stated Eddie Miranda, vice president of Quality at Cytovance Biologics. “I am proud of the entire Cytovance team who achieved such a success. This major milestone paved the way for Cytovance Biologics to enter commercial manufacturing of biopharmaceuticals beyond clinical production.  Cytovance remains committed to providing the highest quality and long-term services to its clients.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics